The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.

Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.

Parent entities and officers
Active 5
  • 1
    Gallagher, Carol Giltner, Dr
    Director born in June 1964
    Individual (1 offspring)
    Officer
    2020-09-25 ~ now
    OF - Director → CIF 0
  • 2
    Erwin.jr., Marion Johnston
    Pharmaceutical Medical Researcher born in May 1961
    Individual (1 offspring)
    Officer
    2020-09-21 ~ now
    OF - Director → CIF 0
  • 3
    Coy, Travis Alan
    Vice President - Corporate Business Development born in July 1980
    Individual (1 offspring)
    Officer
    2021-07-13 ~ now
    OF - Director → CIF 0
  • 4
    Ross, Michael Jay
    Born in July 1949
    Individual (2 offsprings)
    Officer
    2020-01-12 ~ now
    OF - Director → CIF 0
  • 5
    Hirth, Peter, Dr.
    Director born in June 1951
    Individual (1 offspring)
    Officer
    2019-06-24 ~ now
    OF - Director → CIF 0
Ceased 7
  • 1
    Edwards, Timothy Peter Warren
    Chief Operating Officer born in October 1956
    Individual (11 offsprings)
    Officer
    2018-05-04 ~ 2018-12-31
    OF - Director → CIF 0
  • 2
    Bingham, Catherine Elizabeth, Dame
    Director born in October 1965
    Individual (12 offsprings)
    Officer
    2018-01-30 ~ 2020-01-12
    OF - Director → CIF 0
  • 3
    Rao, Ravichandran Nott, Dr
    Director born in July 1973
    Individual
    Officer
    2018-11-12 ~ 2021-03-17
    OF - Director → CIF 0
  • 4
    Trbovic, Nikola
    Corporate Investor born in March 1982
    Individual (3 offsprings)
    Officer
    2019-05-15 ~ 2022-01-12
    OF - Director → CIF 0
  • 5
    Bolger, Jeanne Elizabeth
    Medical Doctor/Company Executive born in February 1969
    Individual (1 offspring)
    Officer
    2019-05-15 ~ 2022-04-29
    OF - Director → CIF 0
  • 6
    Ashrafian, Houman, Professor
    Venture Partner / Professor born in February 1975
    Individual (12 offsprings)
    Officer
    2018-01-30 ~ 2022-04-21
    OF - Director → CIF 0
    Professor Houman Ashrafian
    Born in February 1975
    Individual (12 offsprings)
    Person with significant control
    2018-01-30 ~ 2018-06-05
    PE - Ownership of voting rights - More than 25% but not more than 50%CIF 0
    PE - Right to appoint or remove directorsCIF 0
  • 7
    Wasserman, Heather Anong, Dr.
    Scientist born in November 1973
    Individual
    Officer
    2019-05-15 ~ 2020-09-21
    OF - Director → CIF 0
parent relation
Company in focus

TREX BIO LIMITED

Previous name
CINGULARITY THERAPEUTICS LIMITED - 2018-05-31
Standard Industrial Classification
72110 - Research And Experimental Development On Biotechnology
Brief company account
Fixed Assets - Investments
8 GBP2020-12-31
8 GBP2019-12-31
Fixed Assets
8 GBP2020-12-31
8 GBP2019-12-31
Debtors
1,375,579 GBP2020-12-31
3,075,474 GBP2019-12-31
Cash at bank and in hand
15,071,762 GBP2020-12-31
13,752,853 GBP2019-12-31
Current Assets
16,447,341 GBP2020-12-31
16,828,327 GBP2019-12-31
Creditors
Amounts falling due within one year
-1,473,907 GBP2020-12-31
-896,475 GBP2019-12-31
Net Current Assets/Liabilities
14,973,434 GBP2020-12-31
15,931,852 GBP2019-12-31
Total Assets Less Current Liabilities
14,973,442 GBP2020-12-31
15,931,860 GBP2019-12-31
Creditors
Amounts falling due after one year
-1,535,619 GBP2020-12-31
-4,044,275 GBP2019-12-31
Net Assets/Liabilities
13,437,823 GBP2020-12-31
11,887,585 GBP2019-12-31
Equity
Called up share capital
1 GBP2020-12-31
1 GBP2019-12-31
Share premium
29,657,818 GBP2020-12-31
17,731,232 GBP2019-12-31
Retained earnings (accumulated losses)
-16,219,996 GBP2020-12-31
-5,843,648 GBP2019-12-31
Equity
13,437,823 GBP2020-12-31
11,887,585 GBP2019-12-31
Average Number of Employees
02020-01-01 ~ 2020-12-31
12019-01-01 ~ 2019-12-31
Debtors
Amounts falling due after one year
1,066,280 GBP2020-12-31
1,100,146 GBP2019-12-31

  • TREX BIO LIMITED
    Info
    CINGULARITY THERAPEUTICS LIMITED - 2018-05-31
    Registered number 11176257
    1 More London Place, London SE1 2AF
    Private Limited Company incorporated on 2018-01-30 (7 years 5 months). The company status is Liquidation.
    The last date of confirmation statement was made at 2022-01-29
    CIF 0
child relation
Offspring entities and appointments
Active 0
  • Not found in our database.
© 2022-2025 Polylogarithmic Technology Ltd. All rights reserved.
Contains public sector information retrieved at 24 April 2025 and licensed under the Open Government Licence v3.0.